メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
川治 崇泰
医学部・麻酔・侵襲制御医学
h-index
77
被引用数
6
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2016
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(20)
類似のプロファイル
(6)
フィンガープリント
Takahiro Kawajiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Return Temperature
90%
Blood Differentials
90%
Chamber Structure
90%
Blood Return
90%
Decreased Cardiac Output
90%
Blood Type O
90%
Cytokine Removal
90%
Ionic Interaction
90%
Tension Pneumothorax
90%
Full Stomach
90%
Transpulmonary Thermodilution
90%
Differential Injection
90%
Cold Saline
90%
Venous Thromboembolism Prevention
90%
Septic Patients
90%
Management Center
90%
Prismaflex
60%
Endotoxin Removal
45%
Post-esophagectomy
38%
Jugular Vein
34%
Coagulation Status
33%
Thermostat
30%
Nasogastric Tube Placement
25%
Fixation Rate
22%
Closed Circuit
22%
Priming Volume
22%
Sepsis-related Organ Failure Assessment Score
22%
Sepsis Mortality
22%
Compression Ultrasonography
20%
Lung Rest
18%
Small Modification
18%
Drainage Condition
18%
Return Flow
18%
Potential Practical Application
18%
Cytokine Clearance
18%
Optimal Hemodynamics
18%
Mechanical Displacement
18%
Dysregulated Host Response
15%
Hydrophobic Binding
15%
Immune System Response
15%
Host Response to Infection
15%
Corynebacterium Striatum
15%
Preoperative Consultation
15%
Drug Bioavailability
12%
Septic Acute Kidney Injury
12%
Adsorption Membrane
12%
Adsorption Properties
12%
Possible Complications
12%
Tachypnea
12%
Extubated
12%
Medicine and Dentistry
Liver Polycystic Disease
90%
Venous Thromboembolism
90%
Observational Study
90%
Tumor Lysis Syndrome
90%
Linezolid
90%
Endotoxin
90%
Hemodynamic
90%
Polymyxin
90%
Tension Pneumothorax
90%
Lactic Acid
90%
In Vitro
90%
Disseminated Intravascular Coagulation
90%
Transesophageal Echocardiography
90%
Liver Transplantation
90%
Continuous Kidney Replacement Therapy
60%
Bleeding
45%
Polymyxin B
36%
Hepatomegaly
30%
Echography
27%
Pulmonary Embolism
27%
Organ Dysfunction Score
18%
Chest X-Ray Images
18%
Anticoagulant Therapy
18%
Thromboprophylaxis
18%
Sepsis
16%
Inferior Vena Cava
15%
Hemodynamic Monitoring
15%
Surgeon
15%
Diagnosis
15%
Case Presentation
15%
Corynebacterium striatum
15%
Hemofiltration
12%
Polyacrylonitrile
12%
Drug Bioavailability
12%
Percutaneous Drainage
12%
Tachypnea
12%
Preoperative Period
9%
Septic Shock
9%
Heparin
9%
Fetal Bovine Serum
9%
Retrospective Study
9%
Lower Limb
9%
Direct Oral Anticoagulant
9%
Odds Ratio
8%
Intensive Care Unit
8%
Infection
8%
Subgroup Analysis
8%
Apical Foramen
6%
Pharmacology, Toxicology and Pharmaceutical Science
Septic Shock
100%
Adsorption
90%
Lipopolysaccharide
90%
Tumor Lysis Syndrome
90%
Polymyxin
90%
Burkitt's Lymphoma
90%
Lethality
90%
Endotoxin
90%
Thrombomodulin
90%
Sepsis
54%
Chemotherapy
54%
Cytokine
45%
Interleukin 1
36%
Polymyxin B
36%
Interleukin 6
27%
Synapsin I
18%
Anuria
18%
Survival Rate
18%
Mouse
18%
Infection
18%
Tumor Necrosis Factor
18%
Histone
18%
Ischemia
18%
Inflammation
18%
Endothelium Injury
18%
Sodium Chloride
18%
Severe Renal Impairment
18%
Polyacrylonitrile
12%
Lactate Dehydrogenase
9%
Anticarcinogen
9%
Metabolic Acidosis
9%
High Mobility Group B1 Protein
9%
Respiratory Failure
9%
Hyperuricemia
9%
Replacement Therapy
9%
Disseminated Intravascular Clotting
9%
Hyperkalemia
9%
Acute Kidney Failure
9%
Interleukin 8
9%
